FILTER
Refine your search with the following facets to narrow down your results.
- Biovitrum 4
- Evotec 4
- ion channels 4
- Parkinson's disease 3
- diabetes 3
- diseases 3
- inhibitors 3
- patents 3
- Allergan 2
- Alzheimer's disease 2
- Boehringer Ingelheim 2
- ExonHit Therapeutics 2
- Japan 2
- Sanochemia 2
- adenosine 2
- cancer 2
- central nervous system 2
- dosing 2
- drug discovery collaborations 2
- ion channel drugs 2
- medicine 2
- milestone payments 2
- milestones 2
- multiple sclerosis 2
- obesity 2
- ophthalmology 2
- osteoarthritis 2
- pain treatment 2
- pressure 2
- reductions 2
- regulatory approval 2
- Ablynx 1
- Addex Pharmaceuticals 1
- Alldos 1
- CNS disorders 1
- Carrier 1
- Expression 1
- Galapagos 1
- Germany 1
- HIV 1
- Rett Syndrome 1
- Roche 1
- South Africa 1
- StemCells 1
- Switzerland 1
- Takeda 1
- TransMIT 1
- Tripos 1
- UCB 1
- active pharmaceutical ingredients 1
- amino acids 1
- animal experiments 1
- anxiety disorder 1
- bases 1
- biology 1
- biotechnology 1
- bowel cancer 1
- cannabidiol 1
- cell movement 1
- chemicals 1
- chemistry 1
- chemotherapy 1
- chromatin 1
- cytokines 1
- dopamine 1
- drug delivery 1
- drug development 1
- drug targets 1
- drugs 1
- duloxetine 1
- dyskinesia 1
- enzymes 1
- flow 1
- gastroesophageal reflux disease 1
- gene expression 1
- genetics 1
- glaucoma 1
- informatics 1
- levodopa induced dyskinesia 1
- major depressive disorder 1
- marijuana 1
- medicinal chemistry 1
- migraine 1
- monoclonal antibodies 1
- neurological diseases 1
- neurological disorders 1
- neurotransmitters 1
- oncology 1
- opioids 1
- painkillers 1
- pharmacokinetics 1
- phase III studies 1
- proteins 1
- radicals 1
- receptor agonists 1
- Biovitrum AB 4
- Evotec SE 4
- Allergan, Inc. 2
- Avigen, Inc. 2
- Boehringer Ingelheim Pharma GmbH & Co. KG 2
- ExonHit Therapeutics SA 2
- NeuroDiscovery Ltd 2
- NeuroSolutions Ltd 2
- Sanochemia Pharmazeutika AG 2
- Sosei Co. Ltd. 2
- Ablynx nv 1
- Addex Pharmaceuticals 1
- Affectis Pharmaceuticals AG 1
- Brane Discovery Srl 1
- Cambridge Biotechnology Ltd. 1
- Cannasat Therapeutics 1
- Citigate Dewe Rogerson 1
- College Hill 1
- Consejo Superior De Investigaciones Científias (CSIC) 1
- Drexel University 1
- European Patent Office (EPO) / Europäisches Patentamt (EPA) 1
- Evotec Neurosciences GmbH 1
- Galapagos NV 1
- Imperial College of London 1
- IntelGenx Corp. 1
- Max-Delbrück-Centrum für Molekulare Medizin (MDC) Berlin-Buch 1
- Metabolic Pharmaceuticals Limited 1
- Neurotune AG 1
- Newron Pharmaceuticals SpA 1
- Nuvo Research Inc. 1
- POLYMUN Scientifc Immunbiologische Forschung GmbH 1
- Paladin Labs Inc. 1
- Spinifex Pharmaceuticals 1
- Sun Pharmaceutical Industries Limited 1
- Temple University 1
- The Scripps Research Institute (TSRI) 1
- Tripos, Inc. 1
- U. S. Food and Drug Administration (FDA) 1
- UCB Pharma S.A. 1
- University of Bristol 1
- b3c communications 1
35 Current news about the topic neuropathic pain
FILTERS
Refine your search with the following facets to narrow down your results.
- Biovitrum 4
- Evotec 4
- ion channels 4
- Parkinson's disease 3
- diabetes 3
- diseases 3
- inhibitors 3
- patents 3
- Allergan 2
- Alzheimer's disease 2
- Boehringer Ingelheim 2
- ExonHit Therapeutics 2
- Japan 2
- Sanochemia 2
- adenosine 2
- cancer 2
- central nervous system 2
- dosing 2
- drug discovery collaborations 2
- ion channel drugs 2
- medicine 2
- milestone payments 2
- milestones 2
- multiple sclerosis 2
- obesity 2
- ophthalmology 2
- osteoarthritis 2
- pain treatment 2
- pressure 2
- reductions 2
- regulatory approval 2
- Ablynx 1
- Addex Pharmaceuticals 1
- Alldos 1
- CNS disorders 1
- Carrier 1
- Expression 1
- Galapagos 1
- Germany 1
- HIV 1
- Rett Syndrome 1
- Roche 1
- South Africa 1
- StemCells 1
- Switzerland 1
- Takeda 1
- TransMIT 1
- Tripos 1
- UCB 1
- active pharmaceutical ingredients 1
- amino acids 1
- animal experiments 1
- anxiety disorder 1
- bases 1
- biology 1
- biotechnology 1
- bowel cancer 1
- cannabidiol 1
- cell movement 1
- chemicals 1
- chemistry 1
- chemotherapy 1
- chromatin 1
- cytokines 1
- dopamine 1
- drug delivery 1
- drug development 1
- drug targets 1
- drugs 1
- duloxetine 1
- dyskinesia 1
- enzymes 1
- flow 1
- gastroesophageal reflux disease 1
- gene expression 1
- genetics 1
- glaucoma 1
- informatics 1
- levodopa induced dyskinesia 1
- major depressive disorder 1
- marijuana 1
- medicinal chemistry 1
- migraine 1
- monoclonal antibodies 1
- neurological diseases 1
- neurological disorders 1
- neurotransmitters 1
- oncology 1
- opioids 1
- painkillers 1
- pharmacokinetics 1
- phase III studies 1
- proteins 1
- radicals 1
- receptor agonists 1
- Biovitrum AB 4
- Evotec SE 4
- Allergan, Inc. 2
- Avigen, Inc. 2
- Boehringer Ingelheim Pharma GmbH & Co. KG 2
- ExonHit Therapeutics SA 2
- NeuroDiscovery Ltd 2
- NeuroSolutions Ltd 2
- Sanochemia Pharmazeutika AG 2
- Sosei Co. Ltd. 2
- Ablynx nv 1
- Addex Pharmaceuticals 1
- Affectis Pharmaceuticals AG 1
- Brane Discovery Srl 1
- Cambridge Biotechnology Ltd. 1
- Cannasat Therapeutics 1
- Citigate Dewe Rogerson 1
- College Hill 1
- Consejo Superior De Investigaciones Científias (CSIC) 1
- Drexel University 1
- European Patent Office (EPO) / Europäisches Patentamt (EPA) 1
- Evotec Neurosciences GmbH 1
- Galapagos NV 1
- Imperial College of London 1
- IntelGenx Corp. 1
- Max-Delbrück-Centrum für Molekulare Medizin (MDC) Berlin-Buch 1
- Metabolic Pharmaceuticals Limited 1
- Neurotune AG 1
- Newron Pharmaceuticals SpA 1
- Nuvo Research Inc. 1
- POLYMUN Scientifc Immunbiologische Forschung GmbH 1
- Paladin Labs Inc. 1
- Spinifex Pharmaceuticals 1
- Sun Pharmaceutical Industries Limited 1
- Temple University 1
- The Scripps Research Institute (TSRI) 1
- Tripos, Inc. 1
- U. S. Food and Drug Administration (FDA) 1
- UCB Pharma S.A. 1
- University of Bristol 1
- b3c communications 1